Impressive results from phase 3 RESONATE trial in CLL
The next steps and updated guidelines for the use of MRD concepts in multiple myeloma
Guidance on how to prevent infections in patients with CLL
Combining ublituximab with the novel PI3K inhibitor TGR-1202 for CLL
How can we monitor a patient’s quality of life?